Inhibition of Soluble Epoxide Hydrolase by trans-4- [4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid Is Protective Against Ischemia–Reperfusion Injury-Reference-Cited by-同舟云学术

Inhibition of Soluble Epoxide Hydrolase by trans-4- [4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid Is Protective Against Ischemia–Reperfusion Injury

Published:2010-01 Issue:1 Volume:55 Page:67-73
ISSN:0160-2446
Container-title:Journal of Cardiovascular Pharmacology
language:en
Short-container-title:

Author:

Chaudhary Ketul R,Abukhashim Mohamed,Hwang Sung Hee,Hammock Bruce D,Seubert John M

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Pharmacology

Reference31 articles.

1. Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function.;Seubert;Circ Res,2006

2. Role of epoxyeicosatrienoic acids in protecting the myocardium following ischemia/reperfusion injury.;Seubert;Prostaglandins Other Lipid Mediat,2007

3. Action of epoxyeicosatrienoic acids on cellular function.;Spector;Am J Physiol Cell Physiol,2007

4. Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function.;Spector;Prog Lipid Res,2004

5. The soluble epoxide hydrolase as a pharmaceutical target for hypertension.;Chiamvimonvat;J Cardiovasc Pharmacol,2007

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design and Synthesis of sEH/HDAC6 Dual-Targeting Inhibitors for the Treatment of Inflammatory Pain;Journal of Medicinal Chemistry;2024-07-21

2. Disruption of Ephx2 in cardiomyocytes but not endothelial cells improves functional recovery after ischemia-reperfusion in isolated mouse hearts;Journal of Biological Chemistry;2023-04

3. To Evaluate the Cardioprotective effect of Hydroalcoholic Extract of Matricaria chamomilla Linn in Isoproterenol Induced Myocardial Infarction in Wistar Rats;Research Journal of Pharmacy and Technology;2022-09-28

4. The roles of eicosanoids in myocardial diseases;Advances in Pharmacology;2022

5. Epoxylipids and soluble epoxide hydrolase in heart diseases;Biochemical Pharmacology;2022-01